People: Syngenta AG (SYNN.VX)
383.50CHF
11:31am EDT
CHF-3.10 (-0.80%)
CHF386.60
CHF385.60
CHF386.80
CHF382.10
431,814
242,048
CHF416.00
CHF295.30
Witmer, Juerg
Brief Biography
Mr. Juerg Witmer has been Non-Executive Independent Vice Chairman of the Board of Syngenta AG since 2009. Mr. Witmer is currently Chairman of Givaudan SA and a Director of Zuellig Group Hong Kong. Until March 2012, he was also Chairman of Clariant AG. He joined Roche (1978) in the legal department and subsequently held a number of positions including Assistant to the CEO, General Manager and China Project Manager of Roche Far East based in Hong Kong, Head of Corporate Communications and Public Affairs at Roche headquarters in Basel, Switzerland, and General Manager of Roche Austria. Thereafter he became Chief Executive Officer of Givaudan Roure (1999) and then Chairman of the Board of Directors of Givaudan (2005).
Basic Compensation
| Total Annual Compensation, CHF | Long-Term Incentive Plans, CHF | All Other, CHF | Fiscal Year Total, CHF |
|---|---|---|---|
| 375,000 | -- | -- | 375,000 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Michel Demare |
234,025 |
Michael Mack |
-- |
Juerg Witmer |
375,000 |
John Ramsay |
-- |
Davor Pisk |
-- |
John Atkin |
-- |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
